Orchid Cellmark (ORCH)

[hasbro123]

I think the whole thing rests on whether DNA testing is something that can have revs and margins high enough without multiple rev streams.
If not then a sale is the only way to go.
If they go and try to expand the biz and testing is only a segment i have to wonder where they get the money?
Of course it would involve dilution but who would buy shares of this and what could they expand into that would create good revs and margins immeadiately?

Sell it...........or merge..........i can't see how they run it as it stands now.
If sold or merge occurs i would not expect any great premium based on current situation as they are over 300 million in the hole and that debt would be absorbed by whoever buys or nerges.
Of course the board and management will do very well.